Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial.

Roeder F, Lehner B, Schmitt T, Kasper B, Egerer G, Sedlaczek O, Grüllich C, Mechtersheimer G, Wuchter P, Hensley FW, Huber PE, Debus J, Bischof M.

BMC Cancer. 2014 May 20;14:350. doi: 10.1186/1471-2407-14-350.

2.

A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.

Schmitt T, Lehner B, Kasper B, Bischof M, Roeder F, Dietrich S, Dimitrakopoulou-Strauss A, Strauss LG, Mechtersheimer G, Wuchter P, Ho AD, Egerer G.

BMC Cancer. 2011 Dec 7;11:510. doi: 10.1186/1471-2407-11-510.

3.

The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.

Mahmoud O, Dosch A, Kwon D, Pitcher JD, Conway S, Benedetto P, Fernandez G, Trent J, Temple HT, Wolfson AH.

Am J Clin Oncol. 2016 Oct;39(5):528-34. doi: 10.1097/COC.0000000000000087.

PMID:
24879472
4.

Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis.

Roeder F, Ulrich A, Habl G, Uhl M, Saleh-Ebrahimi L, Huber PE, Schulz-Ertner D, Nikoghosyan AV, Alldinger I, Krempien R, Mechtersheimer G, Hensley FW, Debus J, Bischof M.

BMC Cancer. 2014 Aug 27;14:617. doi: 10.1186/1471-2407-14-617.

5.

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, Basso U, Blay JY, Tendero O, Beveridge RD, Ferraresi V, Lugowska I, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Palmerini E, De Sanctis R, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Casali PG.

Lancet Oncol. 2017 Jun;18(6):812-822. doi: 10.1016/S1470-2045(17)30334-0. Epub 2017 May 9.

PMID:
28499583
6.

[Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].

Moureau-Zabotto L, Thomas L, Bui BN, Chevreau C, Stockle E, Martel P, Bonneviale P, Marques B, Coindre JM, Kantor G, Matsuda T, Delannes M.

Cancer Radiother. 2004 Oct;8(5):279-87. French.

PMID:
15561593
7.

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.

Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, Abdel-Rahman S, Daugaard S, Salat C, Wendtner CM, Vujaskovic Z, Wessalowski R, Jauch KW, Dürr HR, Ploner F, Baur-Melnyk A, Mansmann U, Hiddemann W, Blay JY, Hohenberger P; European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC-STBSG); European Society for Hyperthermic Oncology (ESHO).

Lancet Oncol. 2010 Jun;11(6):561-70. doi: 10.1016/S1470-2045(10)70071-1. Epub 2010 Apr 29.

8.

[Neoadjuvant radiochemotherapy in soft tissue sarcomas. Optimization of local functional tumor control].

Sauer R, Schuchardt U, Hohenberger W, Wittekind C, Papadopoulos T, Grabenbauer GG, Fietkau R.

Strahlenther Onkol. 1999 Jun;175(6):259-66. German.

PMID:
10392166
9.

Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.

Alektiar KM, Brennan MF, Singer S.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):202-8.

PMID:
16111590
10.

Intraoperative radiotherapy for extremity soft-tissue sarcomas: can long-term local control be achieved?

Carbó-Laso E, Sanz-Ruiz P, Calvo-Haro JA, Cuervo-Dehesa M, Pérez-Mañanes R, Mediavilla-Santos L, Sánchez-Pérez C, Álvarez-González A, Vaquero-Martín J.

Int J Clin Oncol. 2017 Dec;22(6):1094-1102. doi: 10.1007/s10147-017-1162-6. Epub 2017 Jul 17.

PMID:
28717856
11.

[Complications and short-term outcomes of intraoperative electron radiotherapy (IOERT) in patients with periarticular soft-tissue sarcomas of the extremities].

Fan CC, Feng QF, Zhai YR, Li MH, Xu LB, Zhao ZG, Chen XY, Hu ZH, Zhang YQ, Yu SJ.

Zhonghua Zhong Liu Za Zhi. 2012 Apr;34(4):311-5. doi: 10.3760/cma.j.issn.0253-3766.2012.04.016. Chinese.

PMID:
22781047
12.

External-beam radiation therapy combined with limb-sparing surgery in elderly patients (>70 years) with primary soft tissue sarcomas of the extremities : A retrospective analysis.

Andrä C, Klein A, Dürr HR, Rauch J, Lindner LH, Knoesel T, Angele M, Baur-Melnyk A, Belka C, Roeder F.

Strahlenther Onkol. 2017 Aug;193(8):604-611. doi: 10.1007/s00066-017-1109-x. Epub 2017 Feb 22.

PMID:
28229172
13.

Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas.

Petersen IA, Haddock MG, Donohue JH, Nagorney DM, Grill JP, Sargent DJ, Gunderson LL.

Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):469-75.

PMID:
11872294
14.

Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.

Kraybill WG, Harris J, Spiro IJ, Ettinger DS, DeLaney TF, Blum RH, Lucas DR, Harmon DC, Letson GD, Eisenberg B; Radiation Therapy Oncology Group Trial 9514.

J Clin Oncol. 2006 Feb 1;24(4):619-25.

PMID:
16446334
15.

Intraoperative electron radiation therapy combined with external beam radiation therapy and limb sparing surgery in extremity soft tissue sarcoma: a retrospective single center analysis of 183 cases.

Roeder F, Lehner B, Saleh-Ebrahimi L, Hensley FW, Ulrich A, Alldinger I, Mechtersheimer G, Huber PE, Krempien R, Bischof M, Debus J, Uhl M.

Radiother Oncol. 2016 Apr;119(1):22-9. doi: 10.1016/j.radonc.2015.11.014. Epub 2015 Dec 1.

PMID:
26651593
16.

Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas.

DeLaney TF, Spiro IJ, Suit HD, Gebhardt MC, Hornicek FJ, Mankin HJ, Rosenberg AL, Rosenthal DI, Miryousefi F, Ancukiewicz M, Harmon DC.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1117-27.

PMID:
12829150
17.

Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas.

Mullen JT, Kobayashi W, Wang JJ, Harmon DC, Choy E, Hornicek FJ, Rosenberg AE, Chen YL, Spiro IJ, DeLaney TF.

Cancer. 2012 Aug 1;118(15):3758-65. doi: 10.1002/cncr.26696. Epub 2011 Dec 16.

18.

Prognostic value of external beam radiation therapy in patients treated with surgical resection and intraoperative electron beam radiation therapy for locally recurrent soft tissue sarcoma: a multicentric long-term outcome analysis.

Calvo FA, Sole CV, Cambeiro M, Montero A, Polo A, Gonzalez C, Cuervo M, San Julian M, Garcia-Sabrido JL, Martinez-Monge R.

Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):143-50. doi: 10.1016/j.ijrobp.2013.10.021.

PMID:
24331661
19.

Intraoperative radiotherapy electron boost followed by moderate doses of external beam radiotherapy in resected soft-tissue sarcoma of the extremities.

Azinovic I, Martinez Monge R, Javier Aristu J, Salgado E, Villafranca E, Fernandez Hidalgo O, Amillo S, San Julian M, Villas C, Manuel Aramendía J, Calvo FA.

Radiother Oncol. 2003 Jun;67(3):331-7.

PMID:
12865183
20.

Anticipated intraoperative electron beam boost, external beam radiation therapy, and limb-sparing surgical resection for patients with pediatric soft-tissue sarcomas of the extremity: a multicentric pooled analysis of long-term outcomes.

Sole CV, Calvo FA, Polo A, Cambeiro M, Alvarez A, Gonzalez C, Gonzalez J, San Julian M, Martinez-Monge R.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):172-80. doi: 10.1016/j.ijrobp.2014.05.026.

PMID:
25195992

Supplemental Content

Support Center